IRIS
MONTOMOLI, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.277
NA - Nord America 9.189
AS - Asia 1.205
OC - Oceania 13
SA - Sud America 12
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.707
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.154
GB - Regno Unito 4.805
IE - Irlanda 1.753
IT - Italia 909
CN - Cina 904
UA - Ucraina 811
SE - Svezia 753
FR - Francia 471
DE - Germania 353
FI - Finlandia 254
VN - Vietnam 190
ES - Italia 38
BE - Belgio 31
CA - Canada 25
RU - Federazione Russa 21
IN - India 19
KR - Corea 19
TR - Turchia 19
NL - Olanda 11
AU - Australia 10
AT - Austria 9
IR - Iran 7
JP - Giappone 7
BR - Brasile 6
CH - Svizzera 5
DK - Danimarca 5
GR - Grecia 5
HK - Hong Kong 5
LU - Lussemburgo 5
MX - Messico 5
SG - Singapore 5
EU - Europa 4
HU - Ungheria 4
PL - Polonia 4
RO - Romania 4
AM - Armenia 3
ID - Indonesia 3
LT - Lituania 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
AL - Albania 2
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
EG - Egitto 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
TW - Taiwan 2
ZA - Sudafrica 2
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GL - Groenlandia 1
IL - Israele 1
IM - Isola di Man 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 20.707
Salva come PNG Salva come JPEG
Città #
Southend 4.623
Dublin 1.737
Fairfield 1.471
Chandler 987
Ashburn 726
Woodbridge 710
Jacksonville 681
Houston 590
Wilmington 566
Seattle 548
Cambridge 470
Ann Arbor 406
Siena 346
Princeton 282
Nanjing 229
Dong Ket 189
Beijing 162
San Mateo 118
San Diego 113
Boardman 110
Helsinki 107
Nanchang 74
Shenyang 52
Shanghai 49
Tianjin 47
Hebei 42
Rome 38
Málaga 37
Kunming 34
Lappeenranta 34
Florence 32
Jiaxing 32
Brussels 30
London 28
New York 28
Norwalk 28
Dearborn 25
Changsha 24
Hangzhou 24
Jinan 23
Milan 22
Redwood City 20
Phoenix 18
Lancaster 17
Ningbo 17
Genova 16
Toronto 16
Fremont 14
San Francisco 14
Taizhou 13
Zhengzhou 12
Guangzhou 11
Izmir 11
Auburn Hills 9
Fuzhou 9
Los Angeles 9
Vienna 9
Changchun 8
Düsseldorf 8
Roccagorga 8
Bologna 7
Dessau 7
Washington 7
Bari 6
Chicago 6
Hounslow 6
Kilburn 6
Lanzhou 6
Melbourne 6
Mestre 6
Parma 6
Philadelphia 6
Stockholm 6
Torre Del Greco 6
Amsterdam 5
Frankfurt am Main 5
Luxembourg 5
Mumbai 5
Naples 5
Pisa 5
Prescot 5
Renton 5
Venezia 5
Andover 4
Atlanta 4
Brescia 4
Budapest 4
Cagliari 4
Carmignano 4
Copenhagen 4
Groningen 4
Islington 4
Messina 4
Monteriggioni 4
Oliveto Citra 4
Paris 4
Perugia 4
Singapore 4
São Paulo 4
Tappahannock 4
Totale 16.313
Salva come PNG Salva come JPEG
Nome #
A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses 492
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 451
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 446
Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains 428
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 396
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 388
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 371
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 347
Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice 216
Egg-Independent Influenza Vaccines and Vaccine Candidates 208
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 206
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 185
Moderate vaccine effectiveness against severe acute respiratory infection caused by a(H1N1)pdm09 influenza virus and no effectiveness against a(H3N2) influenza virus in the 2018/2019 season in Italy 180
Flucelvax (Optaflu) for seasonal influenza 176
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 175
Influenza immunology evaluation and correlates of protection: a focus on vaccines 171
Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination 164
Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season 164
A method for detection of neuraminidase antibody in serum 162
Emerging influenza strains in the last two decades: A threat of a new pandemic? 162
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 161
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 157
Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention 153
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 151
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season 147
Challenges in the development of egg-independent vaccines for influenza 147
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses 146
Early rise of blood T follicular helper cell subsets and baseline immunity as predictors of persisting late functional antibody responses to vaccination in humans 144
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004) 144
Neisseria meningitidis infection: Who, when and where? 140
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 140
Impact of erythrocyte species on assays for influenza serology 139
Influenza vaccines: Evaluation of the safety profile 139
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 138
Immunogenicity and safety of the new inactivated quadrivalent influenza vaccine vaxigrip tetra: Preliminary results in children ≥6 months and older adults 138
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine 137
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza 137
null 136
Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines 135
How much ozone bactericidal activity is compromised by plasma components? 134
Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention 133
N. meningitidis and TLR polymorphisms: A fascinating immunomodulatory network 132
Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the icelandic population whereas disease and medication have small effects 131
Live attenuated influenza vaccine in children induces b-cell responses in tonsils 130
null 130
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice 129
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 129
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture 129
RT-PCR multiplex per l’identificazione simultanea di influenza virus A/H1N1 A/H3N2 e B e Virus Respiratorio Sinciziale di tipo A e B 128
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 127
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses 125
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines 124
An unwanted guest: Neisseria meningitidis–carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence 123
Fighting Neisseria meningitidis: past and current vaccination strategies 122
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge 122
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates 122
Measles in pregnancy: a threat for Italian women? 121
Is influenza A/H10N8 a potential candidate for the next pandemic? 120
International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE 120
A Cell Culture (Vero)–Derived H5N1 Whole-Virus Vaccine Induces Cross-Reactive Memory Responses 120
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 119
Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence 118
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future 116
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 116
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? 115
Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE) 115
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses 115
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 115
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine 114
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 114
Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania 114
Cost-benefit evaluation of anti-influenza vaccination in the elderly during two influenza seasons in the Siena district [Valutazione benefici-costi della vaccinazione antinfluenzale negli anziani in due stagioni epidemiche a confronto nella provincia di Siena] 114
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy 113
Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period 113
The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants 113
Mapping host-related correlates of influenza vaccine-induced immune response: An umbrella review of the available systematic reviews and meta-analyses 112
Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals 112
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study 111
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 111
Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period 111
Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic 109
Epidemiologia e prevenzione delle malattie dentali a Siena: studio pluriennale (1988-1996) su campioni di alunni della scuola dell'obbligo. 108
Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations 108
null 108
Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy 107
Cross subclade immunity after one-year booster immunization with MF59®-adjuvanted A/H5N1 influenza vaccine in 6 month to 17 year-old children 106
Correlates of protection against influenza 106
Safety, tolerability and immunogenicity of a mammalian cell culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial 104
Current adjuvants and new perspectives in vaccine formulation 102
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in tuscany, Italy 102
Pre-emptive vaccination against pandemic influenza virus 101
Expression of sialic acid influenza receptors in red blood cells from avian and mammalian species: an immunological comparative study 101
Low prevalence of antibodies against pertussis in pregnant women in Italy 99
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 98
The sporicidal effects of a biodegradable peroxidic disinfectant 96
Correlates of protection against influenza 96
The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine 96
Vaccination against Hepatitis B - Lenght of protection among populations at risk 95
Influenza-related mortality in the Italian elderly: No decline associated with increasing vaccination coverage 94
Water and air ozone treatment as an alternative sanitizing technology 94
Totale 15.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.693
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019848 0 0 0 0 0 0 0 0 0 0 390 458
2019/20204.766 504 155 282 625 331 388 376 593 422 438 260 392
2020/20214.814 238 431 214 578 376 503 220 565 369 530 359 431
2021/20222.653 236 394 263 233 100 75 115 174 164 214 225 460
2022/20233.333 201 296 402 480 311 666 90 299 344 62 111 71
2023/20242.352 86 75 187 110 101 589 981 75 27 111 10 0
Totale 21.050